MedTrace Logo

Dose Response Study of a Natural Extract for Reducing Post Prandial Blood Glucose

NCT04256746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2020-02-05

No results posted yet for this study

Summary

Randomized, balanced incomplete block design dose response study of efficacy, with 4 different dosages of mulberry fruit powdered extract added to cooked rice compared to a reference treatment (cooked rice only).

Conditions

  • Blood Glucose

Interventions

OTHER

Boiled Rice

OTHER

Boiled Rice+0.37 gr mulberry fruit powdered extract

OTHER

Boiled Rice+0.75 gr mulberry fruit powdered extract

OTHER

Boiled Rice+1.12 gr mulberry fruit powdered extract

OTHER

Boiled Rice+1.50 gr mulberry fruit powdered extract

OTHER

Rice Porridge

OTHER

Rice porridge+1.50 gr mulberry fruit powdered extract

Sponsors & Collaborators

  • Lambda Therapeutic Research Ltd.

    collaborator INDUSTRY

  • Unilever R&D

    lead INDUSTRY

Principal Investigators

  • David Mela, Dr. · Unilever R&D Vlaardingen (retired)

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-09-24
Primary Completion
2012-10-19
Completion
2012-10-19

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04256746 on ClinicalTrials.gov